Bath & Body Works, Inc.
BBWINYSECIK 701985Consumer Cyclical / Specialty Retailfiscal year ends January73 quarters since 2008
Latest quarter Q2 FY2027, filed August 26, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.
Share price
Daily candlesticks from November 18, 2024 to November 13, 2026, with each earnings release marked; a release after the close marks the day it came out, so its reaction is the next candle. See this earnings season for every company’s reaction.
The last 16 quarters
Q3 FY2023 to Q2 FY2027, through the filing of August 26, 2026.
Net income losses drawn in red.
Operating cash flow less capital expenditures; negative quarters in red.
Positions at each quarter end, as filed; short-term investments are not included.
Income statement
Last eight quarters, newest first, through Q2 FY2027 filed August 26, 2026.
| Millions of dollars | Q2 FY2027ended Aug 1, 2026filed Aug 26, 2026 | Q1 FY2027ended May 2, 2026filed May 27, 2026 | Q4 FY2026ended Jan 31, 2026filed Mar 12, 2026 | Q3 FY2026ended Nov 1, 2025filed Nov 20, 2025 | Q2 FY2026ended Aug 2, 2025filed Aug 28, 2025 | Q1 FY2026ended May 3, 2025filed May 29, 2025 | Q4 FY2025ended Feb 1, 2025filed Mar 14, 2025 | Q3 FY2025ended Nov 2, 2024filed Nov 26, 2024 | YoYQ2 FY2027vs Q2 FY2026 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,514 | 1,378 | 2,724 | 1,594 | 1,549 | 1,424 | 2,787 | 1,610 | −2.3% |
| Cost of revenue | 822 | 791 | 1,480 | 936 | 909 | 778 | 1,486 | 910 | −9.6% |
| Gross profit | 692 | 587 | 1,244 | 658 | 640 | 646 | 1,301 | 700 | +8.1% |
| Research and development | — | — | — | — | — | — | — | — | — |
| Selling, general and administrative | 476 | 356 | 645 | 497 | 483 | 437 | 623 | 482 | −1.4% |
| Operating income | 216 | 231 | 599 | 161 | 157 | 209 | 678 | 218 | +37.6% |
| Other income (expense) | 11 | 4 | 7 | 10 | 6 | 7 | 9 | 4 | +83.3% |
| Pretax income | 164 | 166 | 538 | 103 | 95 | 146 | 611 | 145 | +72.6% |
| Income tax | 46 | (17) | 135 | 26 | 31 | 41 | 158 | 39 | +48.4% |
| Net income | 118 | 183 | 403 | 77 | 64 | 105 | 453 | 106 | +84.4% |
| Diluted EPS ($) | 0.58 | 0.90 | — | 0.37 | 0.30 | 0.49 | — | 0.49 | +93.3% |
| Diluted shares (millions) | 202 | 202 | — | 206 | 211 | 215 | — | 219 | — |
Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.
Balance sheet
Last eight quarters, newest first, through Q2 FY2027 filed August 26, 2026.
| Millions of dollars | Q2 FY2027ended Aug 1, 2026filed Aug 26, 2026 | Q1 FY2027ended May 2, 2026filed May 27, 2026 | Q4 FY2026ended Jan 31, 2026filed Mar 12, 2026 | Q3 FY2026ended Nov 1, 2025filed Nov 20, 2025 | Q2 FY2026ended Aug 2, 2025filed Aug 28, 2025 | Q1 FY2026ended May 3, 2025filed May 29, 2025 | Q4 FY2025ended Feb 1, 2025filed Mar 14, 2025 | Q3 FY2025ended Nov 2, 2024filed Nov 26, 2024 | YoYQ2 FY2027vs Q2 FY2026 |
|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 794 | 820 | 953 | 236 | 364 | 636 | 674 | 191 | +118.1% |
| Short-term investments | — | — | — | — | — | — | — | — | — |
| Total current assets | 2,050 | 1,899 | 2,019 | 1,881 | 1,706 | 1,820 | 1,823 | 1,720 | +20.2% |
| Total assets | 5,156 | 4,963 | 5,069 | 4,989 | 4,814 | 4,881 | 4,872 | 4,984 | +7.1% |
| Total current liabilities | 1,707 | 1,377 | 1,591 | 1,553 | 1,303 | 1,294 | 1,231 | 1,575 | +31.0% |
| Long-term debt | 3,366 | 3,613 | 3,612 | 3,890 | 3,888 | 3,886 | 3,884 | 3,883 | −13.4% |
| Total debt | 3,614 | 3,613 | 3,892 | 3,890 | 3,888 | 3,886 | 3,884 | 4,197 | −7.0% |
| Total liabilities | — | — | — | — | — | — | — | — | — |
| Stockholders’ equity | (1,056) | (1,133) | (1,281) | (1,593) | (1,548) | (1,451) | (1,385) | (1,749) | +31.8% |
| Shares outstanding (millions) | 202 | 202 | 201 | 205 | 206 | 212 | 214 | 217 | — |
Positions at each period end. Long-term debt is the line the filer tags, with or without its current portion. Total debt is one definition across filers, built from filed lines: long-term debt with its current portion plus short-term borrowings, finance leases where the filer folds them into its debt line, operating leases never; it is blank where the tags do not add up to it. Italic figures are derived.
Cash flow statement
Last eight quarters, newest first, through Q2 FY2027 filed August 26, 2026.
| Millions of dollars | Q2 FY2027ended Aug 1, 2026filed Aug 26, 2026 | Q1 FY2027ended May 2, 2026filed May 27, 2026 | Q4 FY2026ended Jan 31, 2026filed Mar 12, 2026 | Q3 FY2026ended Nov 1, 2025filed Nov 20, 2025 | Q2 FY2026ended Aug 2, 2025filed Aug 28, 2025 | Q1 FY2026ended May 3, 2025filed May 29, 2025 | Q4 FY2025ended Feb 1, 2025filed Mar 14, 2025 | Q3 FY2025ended Nov 2, 2024filed Nov 26, 2024 | YoYQ2 FY2027vs Q2 FY2026 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 72 | 244 | 877 | 80 | (43) | 188 | 955 | (99) | +267.4% |
| Capital expenditures | 49 | 49 | 63 | 81 | 56 | 37 | 60 | 65 | −12.5% |
| Free cash flow (CFO − capex) | 23 | 195 | 814 | (1) | (99) | 151 | 895 | (164) | +123.2% |
| Depreciation and amortization | — | — | — | — | — | — | — | — | — |
| Share repurchases | 0 | 0 | 57 | 90 | 118 | 136 | 52 | 101 | −100.0% |
| Dividends paid | 40 | 40 | 41 | 41 | 43 | 42 | 43 | 44 | −7.0% |
10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.
Annual statements
Every fiscal year filed, newest first, through FY2026 filed March 12, 2026.
Income statement
| Millions of dollars | FY2026ended Jan 31, 2026filed Mar 12, 2026 | FY2025ended Feb 1, 2025filed Mar 14, 2025 | FY2024ended Feb 3, 2024filed Mar 22, 2024 | FY2023ended Jan 28, 2023filed Mar 17, 2023 | FY2022ended Jan 29, 2022filed Mar 18, 2022 | FY2021ended Jan 30, 2021filed Mar 19, 2021 | FY2020ended Feb 1, 2020filed Mar 30, 2020 | FY2019ended Feb 2, 2019filed Mar 22, 2019 | FY2018ended Feb 3, 2018filed Mar 23, 2018 | FY2017ended Jan 28, 2017filed Mar 17, 2017 | FY2016ended Jan 30, 2016filed Mar 18, 2016 | FY2015ended Jan 31, 2015filed Mar 20, 2015 | FY2014ended Feb 1, 2014filed Mar 21, 2014 | FY2013ended Feb 2, 2013filed Mar 22, 2013 | FY2012ended Jan 28, 2012filed Mar 23, 2012 | FY2011ended Jan 29, 2011filed Mar 18, 2011 | FY2010ended Jan 30, 2010filed Mar 26, 2010 | FY2009ended Jan 31, 2009filed Sep 4, 2009 | FY2008ended Feb 2, 2008filed Sep 4, 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7,291 | 7,307 | 7,429 | 7,560 | 7,882 | 6,434 | 5,405 | 13,237 | 12,632 | 12,574 | 12,154 | 11,454 | 10,773 | 10,459 | 10,364 | 9,613 | 8,632 | 9,043 | 10,134 |
| Cost of revenue | 4,102 | 4,073 | 4,193 | 4,305 | 4,027 | 3,338 | 3,018 | 8,338 | 7,673 | 7,449 | 6,950 | 6,646 | 6,344 | 6,073 | 6,307 | 5,982 | 5,604 | 6,037 | 6,625 |
| Gross profit | 3,189 | 3,234 | 3,236 | 3,255 | 3,855 | 3,096 | 2,387 | 4,899 | 4,959 | 5,125 | 5,204 | 4,808 | 4,429 | 4,386 | 4,057 | 3,631 | 3,028 | 3,006 | 3,509 |
| Research and development | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Selling, general and administrative | 2,063 | 1,968 | 1,951 | 1,879 | 1,846 | 1,492 | 1,347 | 3,563 | 3,231 | 3,122 | 3,012 | 2,855 | 2,686 | 2,720 | 2,698 | 2,341 | 2,166 | 2,311 | 2,616 |
| Operating income | 1,126 | 1,266 | 1,285 | 1,376 | 2,009 | 1,604 | 1,040 | 1,237 | 1,728 | 2,003 | 2,192 | 1,953 | 1,743 | 1,573 | 1,238 | 1,284 | 868 | 589 | 1,110 |
| Other income (expense) | 32 | 74 | 81 | 17 | (198) | (50) | (62) | 5 | (10) | 87 | 76 | 7 | 17 | 24 | 235 | 175 | 19 | 23 | 128 |
| Pretax income | 882 | 1,028 | 1,021 | 1,045 | 1,423 | 1,122 | 608 | 857 | 1,312 | 1,696 | 1,934 | 1,636 | 1,446 | 1,281 | 1,227 | — | — | — | — |
| Income tax | 233 | 230 | 143 | 251 | 348 | 257 | 148 | 213 | 329 | 538 | 681 | 594 | 543 | 528 | 377 | 446 | 202 | 233 | 411 |
| Net income | 649 | 798 | 878 | 800 | 1,333 | 844 | (366) | 644 | 983 | 1,158 | 1,253 | 1,042 | 903 | 753 | 850 | 805 | 448 | 220 | 718 |
| Diluted EPS ($) | 3.11 | 3.61 | 3.84 | 3.43 | 4.88 | 3.00 | (1.32) | 2.31 | 3.42 | 3.98 | 4.22 | 3.50 | 3.05 | 2.54 | 2.70 | 2.42 | 1.37 | 0.65 | 1.89 |
| Diluted shares (millions) | 209 | 221 | 229 | 233 | 273 | 281 | 278 | 279 | 287 | 291 | 297 | 298 | 296 | 297 | 314 | 333 | 327 | 337 | — |
Balance sheet
| Millions of dollars | FY2026ended Jan 31, 2026filed Mar 12, 2026 | FY2025ended Feb 1, 2025filed Mar 14, 2025 | FY2024ended Feb 3, 2024filed Mar 22, 2024 | FY2023ended Jan 28, 2023filed Mar 17, 2023 | FY2022ended Jan 29, 2022filed Mar 18, 2022 | FY2021ended Jan 30, 2021filed Mar 19, 2021 | FY2020ended Feb 1, 2020filed Mar 30, 2020 | FY2019ended Feb 2, 2019filed Mar 22, 2019 | FY2018ended Feb 3, 2018filed Mar 23, 2018 | FY2017ended Jan 28, 2017filed Mar 17, 2017 | FY2016ended Jan 30, 2016filed Mar 18, 2016 | FY2015ended Jan 31, 2015filed Mar 20, 2015 | FY2014ended Feb 1, 2014filed Mar 21, 2014 | FY2013ended Feb 2, 2013filed Mar 22, 2013 | FY2012ended Jan 28, 2012filed Mar 23, 2012 | FY2011ended Jan 29, 2011filed Mar 18, 2011 | FY2010ended Jan 30, 2010filed Mar 26, 2010 | FY2009ended Jan 31, 2009filed Sep 4, 2009 | FY2008ended Feb 2, 2008filed Sep 4, 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 953 | 674 | 1,084 | 1,232 | 1,979 | 3,568 | 1,499 | 1,413 | 1,515 | 1,934 | 2,548 | 1,681 | 1,681 | 773 | 935 | 1,130 | 1,804 | 1,173 | 1,018 |
| Short-term investments | — | — | — | — | — | — | — | — | — | — | — | 0 | — | — | — | — | — | — | — |
| Total current assets | 2,019 | 1,823 | 2,115 | 2,266 | 3,009 | 5,579 | 3,245 | 3,260 | 3,293 | 3,465 | 4,156 | 3,199 | 3,150 | 2,205 | 2,368 | 2,592 | 3,250 | 2,867 | — |
| Total assets | 5,069 | 4,872 | 5,463 | 5,494 | 6,026 | 11,571 | 10,125 | 8,090 | 8,149 | 8,170 | 8,493 | 7,476 | 7,128 | 6,019 | 6,108 | 6,451 | 7,173 | 6,972 | — |
| Total current liabilities | 1,591 | 1,231 | 1,289 | 1,379 | 1,290 | 2,826 | 2,372 | 1,986 | 2,031 | 2,014 | 1,875 | 1,679 | 1,826 | 1,538 | 1,526 | 1,504 | 1,322 | 1,255 | — |
| Long-term debt | 3,612 | 3,884 | 4,388 | 4,862 | 4,854 | 6,366 | 5,487 | 5,739 | 5,707 | 5,700 | 5,715 | 4,722 | 4,761 | 4,477 | 3,481 | 2,507 | 2,723 | 2,897 | — |
| Total debt | 3,892 | 3,884 | 4,388 | 4,862 | 4,854 | 6,366 | 5,548 | 5,811 | 5,794 | 5,736 | 5,721 | 4,765 | 4,976 | 4,477 | 3,538 | 2,507 | 2,727 | 2,897 | — |
| Total liabilities | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stockholders’ equity | (1,281) | (1,385) | (1,627) | (2,206) | (1,518) | (662) | (1,499) | (869) | (753) | (729) | (259) | 18 | (370) | (1,015) | 137 | 1,476 | 2,183 | 1,874 | — |
| Shares outstanding (millions) | 201 | 214 | 225 | 229 | 239 | 279 | 277 | 275 | 279 | 285 | 287 | 292 | 291 | 288 | 319 | 319 | 323 | — | — |
Cash flow statement
| Millions of dollars | FY2026ended Jan 31, 2026filed Mar 12, 2026 | FY2025ended Feb 1, 2025filed Mar 14, 2025 | FY2024ended Feb 3, 2024filed Mar 22, 2024 | FY2023ended Jan 28, 2023filed Mar 17, 2023 | FY2022ended Jan 29, 2022filed Mar 18, 2022 | FY2021ended Jan 30, 2021filed Mar 19, 2021 | FY2020ended Feb 1, 2020filed Mar 30, 2020 | FY2019ended Feb 2, 2019filed Mar 22, 2019 | FY2018ended Feb 3, 2018filed Mar 23, 2018 | FY2017ended Jan 28, 2017filed Mar 17, 2017 | FY2016ended Jan 30, 2016filed Mar 18, 2016 | FY2015ended Jan 31, 2015filed Mar 20, 2015 | FY2014ended Feb 1, 2014filed Mar 21, 2014 | FY2013ended Feb 2, 2013filed Mar 22, 2013 | FY2012ended Jan 28, 2012filed Mar 23, 2012 | FY2011ended Jan 29, 2011filed Mar 18, 2011 | FY2010ended Jan 30, 2010filed Mar 26, 2010 | FY2009ended Jan 31, 2009filed Sep 4, 2009 | FY2008ended Feb 2, 2008filed Sep 4, 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1,102 | 886 | 954 | 1,144 | 1,492 | 2,039 | 1,236 | 1,377 | 1,406 | 1,990 | 2,027 | 1,786 | 1,248 | 1,351 | 1,266 | 1,284 | 1,174 | 954 | 765 |
| Capital expenditures | 237 | 226 | 298 | 328 | 270 | 228 | 458 | 629 | 707 | 990 | 727 | 715 | 691 | 588 | 426 | 274 | 202 | 479 | 749 |
| Free cash flow (CFO − capex) | 865 | 660 | 656 | 816 | 1,222 | 1,811 | 778 | 748 | 699 | 1,000 | 1,300 | 1,071 | 557 | 763 | 840 | 1,010 | 972 | 475 | 16 |
| Depreciation and amortization | — | — | — | — | — | 521 | 588 | 547 | 524 | 472 | 415 | 398 | 368 | 354 | 356 | 359 | 357 | 377 | 385 |
| Share repurchases | 401 | 401 | 148 | 1,312 | 1,964 | 0 | 0 | 198 | 446 | 435 | 483 | 87 | 60 | 629 | 1,190 | 207 | 0 | 379 | 1,402 |
| Dividends paid | 167 | 177 | 182 | 186 | 120 | 83 | 332 | 666 | 686 | 1,268 | 1,171 | 691 | 349 | 1,449 | 1,144 | 1,488 | 193 | 201 | 227 |
Insider activity
Form 4 filings by officers, directors and 10% owners, November 16, 2024 to November 16, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.
The last 25 transactions
| Traded | Insider | Role | Transaction | Shares | Price | Value | Held after | Filed |
|---|---|---|---|---|---|---|---|---|
| Nov 10, 2026 | Javitch Tom | Interim CFO | award | 11,547 | $0.00 | — | 70,550 | Nov 12, 2026 |
| Oct 16, 2026 | Nash Sarah E | Director | open-market sale | 1 | $20.57 | $14 | 299,101 | Oct 20, 2026 |
| Aug 10, 2026 | Aber Ann | Chief Legal Officer &Corp Secy | award | 12,940 | $0.00 | — | 12,940 | Aug 12, 2026 |
| Jun 12, 2026 | Javitch Tom | Interim CFO | award | 10,309 | $0.00 | — | 59,003 | Jun 15, 2026 |
| Jun 11, 2026 | Voskuil Steven E | Director | award | 7,970 | $0.00 | — | 41,895 | Jun 15, 2026 |
| Jun 11, 2026 | Rajlin Juan | Director | award | 7,970 | $0.00 | — | 24,490 | Jun 15, 2026 |
| Jun 11, 2026 | Symancyk James Kevin | Director | award | 7,970 | $0.00 | — | 48,349 | Jun 15, 2026 |
| Jun 11, 2026 | Lee Danielle M. | Director | award | 7,970 | $0.00 | — | 26,181 | Jun 15, 2026 |
| Jun 11, 2026 | Steinour Stephen D | Director | award | 7,970 | $0.00 | — | 56,145 | Jun 15, 2026 |
| Jun 11, 2026 | Hondal Francis | Director | award | 7,970 | $0.00 | — | 13,611 | Jun 15, 2026 |
| Jun 11, 2026 | Nash Sarah E | Director | award | 13,284 | $0.00 | — | 298,895 | Jun 15, 2026 |
| Jun 11, 2026 | Brady Lucy | Director | award | 7,970 | $0.00 | — | 25,452 | Jun 15, 2026 |
| Jun 11, 2026 | Bogliolo Alessandro | Director | award | 7,970 | $0.00 | — | 24,490 | Jun 15, 2026 |
| May 19, 2026 | Mazurek Thomas E. | Chief Supply Chain Officer | award | 6,616 | $0.00 | — | 119,297 | May 20, 2026 |
| May 19, 2026 | Mazurek Thomas E. | Chief Supply Chain Officer | tax withholding | 4,127 | $16.11 | $66K | 115,170 | May 20, 2026 |
| May 16, 2026 | Heaf Daniel | CEO, Director | tax withholding | 7,334 | $17.09 | $125K | 288,249 | May 19, 2026 |
| Mar 13, 2026 | Mazurek Thomas E. | Chief Supply Chain Officer | tax withholding | 6,327 | $19.50 | $123K | 112,681 | Mar 16, 2026 |
| Mar 13, 2026 | Boratto Eva C | Chief Financial Officer | tax withholding | 10,782 | $19.50 | $210K | 223,459 | Mar 16, 2026 |
| Mar 12, 2026 | Heaf Daniel | CEO, Director | award | 212,993 | $0.00 | — | 295,583 | Mar 16, 2026 |
| Mar 12, 2026 | Mazurek Thomas E. | Chief Supply Chain Officer | award | 40,921 | $0.00 | — | 118,654 | Mar 16, 2026 |
| Mar 12, 2026 | Boratto Eva C | Chief Financial Officer | award | 115,815 | $0.00 | — | 234,241 | Mar 16, 2026 |
| Nov 24, 2025 | Symancyk James Kevin | Director | open-market buy | 22,500 | $15.58 | $351K | 40,379 | Nov 25, 2025 |
| Nov 24, 2025 | Nash Sarah E | Director | open-market buy | 10,000 | $15.58 | $156K | 285,522 | Nov 25, 2025 |
| Nov 21, 2025 | Voskuil Steven E | Director | open-market buy | 20,000 | $15.04 | $301K | 33,925 | Nov 24, 2025 |
| Nov 21, 2025 | Steinour Stephen D | Director | open-market buy | 6,700 | $14.86 | $100K | 48,175 | Nov 24, 2025 |
Full insider history for Bath & Body Works, Inc., or insider activity across all companies. A record of filings, not a recommendation.
Tracked funds holding it
1 of the tracked managers held BBWI in their latest 13F filing, through November 12, 2026. Weight is the share of the fund’s reported portfolio. How the funds have traded BBWI by quarter.
| Fund | Manager | Quarter | Value | Shares | Weight | Move |
|---|---|---|---|---|---|---|
| Renaissance Technologies | Peter Brown | Q3 2026 | $59M | 4M | 0.08% | trimmed −7.6% |
Sources
Fiscal year ends in month 1; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.
- Filer
- BATH & BODY WORKS, INC., CIK 701985 on EDGAR
- Extract generated
- November 16, 2026
- Withheld
- 7 line-years whose four quarters do not sum to the filed year: gross profit FY2020, operating income FY2020, pretax income FY2020, revenue FY2020, cost of revenue FY2021, income tax FY2021, opex sga FY2021
- Repaired
- none
XBRL concepts behind each line
Income statement
RevenueFromContractWithCustomerExcludingAssessedTax, SalesRevenueNetCostOfGoodsAndServicesSoldGrossProfitSellingGeneralAndAdministrativeExpenseOperatingIncomeLossOtherNonoperatingIncomeExpenseIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest, IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsIncomeTaxExpenseBenefitNetIncomeLossEarningsPerShareDilutedWeightedAverageNumberOfDilutedSharesOutstandingBalance sheet
CashAndCashEquivalentsAtCarryingValueMarketableSecuritiesCurrentAssetsCurrentAssetsLiabilitiesCurrentLongTermDebtNoncurrentLongTermDebt, combined, noncurrent, noncurrent+currentStockholdersEquitydei:EntityCommonStockSharesOutstandingCash flow statement
NetCashProvidedByUsedInOperatingActivitiesPaymentsToAcquirePropertyPlantAndEquipmentDepreciationAmortizationAndAccretionNet, DepreciationAndAmortization, DepreciationDepletionAndAmortizationPaymentsForRepurchaseOfCommonStockPaymentsOfDividends, PaymentsOfDividendsCommonStockThe data
The statements on this page as files, generated November 16, 2026.
- JSON file
/data/financials/BBWI.json